Phathom Pharmaceuticals Announces Leadership Transition in 2025

Story Highlights
Phathom Pharmaceuticals Announces Leadership Transition in 2025

An announcement from Phathom Pharmaceuticals ( (PHAT) ) is now available.

Phathom Pharmaceuticals announced a leadership transition effective April 1, 2025, with Steven Basta appointed as the new Chief Executive Officer, President, and Class I director, succeeding Terrie Curran who resigned for personal reasons. The company also adopted a 2025 Employment Inducement Incentive Award Plan to attract new talent, reserving 2,500,000 shares for equity awards. This strategic move aims to strengthen the company’s leadership and incentivize new hires, potentially impacting its market position and stakeholder interests.

More about Phathom Pharmaceuticals

YTD Price Performance: -14.46%

Average Trading Volume: 1,130,160

Technical Sentiment Signal: Buy

Current Market Cap: $459.6M

See more data about PHAT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App